These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38607762)

  • 1. Non-Pharmacological Interventions for Depression and Anxiety in Parkinson's Disease.
    van Wegen EEH; van Balkom TD; Hirsch MA; Rutten S; van den Heuvel OA
    J Parkinsons Dis; 2024; 14(s1):S135-S146. PubMed ID: 38607762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-Behavioral Therapy for Anxiety in Parkinson's Disease.
    Reynolds GO; Saint-Hilaire M; Thomas CA; Barlow DH; Cronin-Golomb A
    Behav Modif; 2020 Jul; 44(4):552-579. PubMed ID: 30931594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease.
    Egan SJ; Laidlaw K; Starkstein S
    J Parkinsons Dis; 2015; 5(3):443-51. PubMed ID: 26406124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review.
    Angelopoulou E; Stanitsa E; Karpodini CC; Bougea A; Kontaxopoulou D; Fragkiadaki S; Koros C; Georgakopoulou VE; Fotakopoulos G; Koutedakis Y; Piperi C; Papageorgiou SG
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for the MIND-PD study: a randomized controlled trial to investigate clinical and biological effects of mindfulness-based cognitive therapy in people with Parkinson's disease.
    van der Heide A; Goltz F; de Vries NM; Bloem BR; Speckens AE; Helmich RC
    BMC Neurol; 2024 Jun; 24(1):219. PubMed ID: 38918695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions for depression and anxiety in Parkinson's disease.
    Yang S; Sajatovic M; Walter BL
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):113-21. PubMed ID: 22689704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reward and Punishment Learning as Predictors of Cognitive Behavioral Therapy Response in Parkinson's Disease Comorbid with Clinical Depression.
    Perskaudas R; Myers CE; Interian A; Gluck MA; Herzallah MM; Baum A; Dobkin RD
    J Geriatr Psychiatry Neurol; 2024 Jul; 37(4):282-293. PubMed ID: 38158704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
    Troeung L; Egan SJ; Gasson N
    PLoS One; 2013; 8(11):e79510. PubMed ID: 24236141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: A systematic review and meta-analysis.
    Zhang Q; Yang X; Song H; Jin Y
    Complement Ther Clin Pract; 2020 May; 39():101111. PubMed ID: 32379650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote delivery of psychological interventions for Parkinson's disease.
    Swalwell C; Pachana NA; Dissanayaka NN
    Int Psychogeriatr; 2018 Dec; 30(12):1783-1795. PubMed ID: 29747712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Growing Role of Cognitive Behavior Therapy in the Treatment of Parkinson's Disease.
    Lopes SR; Khan S; Chand S
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):310-320. PubMed ID: 34219525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach.
    Dobkin RD; Menza M; Bienfait KL
    Expert Rev Neurother; 2008 Jan; 8(1):27-35. PubMed ID: 18088199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment.
    Chen J; He P; Zhang Y; Gao Y; Qiu Y; Li Y; Zhang Q; Wang L; Huang Z; Zhao J; Nie K; Wang L
    Int J Neurosci; 2021 Apr; 131(4):411-424. PubMed ID: 32253965
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
    Pontone GM; Mills KA
    Am J Geriatr Psychiatry; 2021 Jun; 29(6):530-540. PubMed ID: 33648830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing depression and anxiety symptoms in patients with Parkinson's disease: The effectiveness of group cognitive behavioral therapy.
    Rezazadeh Yazd SA; Gashtil S; Moradpoor M; Pishdar S; Nabian P; Kazemi Z; Naeim M
    Parkinsonism Relat Disord; 2023 Jul; 112():105456. PubMed ID: 37244105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.
    Armento ME; Stanley MA; Marsh L; Kunik ME; York MK; Bush AL; Calleo JS
    J Parkinsons Dis; 2012; 2(2):135-51. PubMed ID: 23939438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines based on evidence for cognitive-behavioural therapy in Parkinson's disease comorbidities: A literature review.
    Zečević I
    Clin Psychol Psychother; 2020 Jul; 27(4):504-514. PubMed ID: 32196842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.
    Williams NR; Bentzley BS; Sahlem GL; Pannu J; Korte JE; Revuelta G; Short EB; George MS
    Acta Neurol Scand; 2017 Apr; 135(4):407-411. PubMed ID: 27241213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review.
    Koychev I; Okai D
    Evid Based Ment Health; 2017 Feb; 20(1):15-20. PubMed ID: 28073810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease.
    Dobkin RD; Mann SL; Interian A; Gara MA; Menza M
    Int J Geriatr Psychiatry; 2019 May; 34(5):722-729. PubMed ID: 30714202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.